# Adi Goldin

> Adi Goldin is a Series C investor at Docor International Management backing Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Docor International Management](https://shizune.co/investors/profile/docor-international-management)
- Total investments: 2
- Last investment: Nov 2012
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/goldin

Adi Goldin is a Series C investor at Docor International Management focused on Health Care and Biotechnology. Mr. Adi Goldin joined Docor International Management in 2004. Prior to joining Docor, he served as a Director of Investments and Analysis at Inventech Venture Capital, a public company which is traded on the Tel Aviv Stock Exchange. Before working at Inventech, Mr. Goldin practiced law at Israeli, Blustein, Kogan & Co. In addition, he was partof the teaching staff of the MBA program run jointly by Tel Aviv University and Northwestern University`s Kellogg School of Management (Chicago, USA). Mr. Goldin participated in the International Marketing Program and the Global Consulting Program, a joint project of Pennsylvania University`s Wharton Business School and Tel Aviv University`s Business School. Mr. Goldin is an associate of the Israel Bar Association. He holds M.A. and B.A degrees in Economics, both with outstanding honors, and an LL.B in Law – all from Tel Aviv University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 1 | 50% |
| Series E | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EarlySense | EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts. | $15M | Series E | Nov 12, 2012 |  |
| EarlySense | EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts. | $13M | Series C | Jul 23, 2010 |  |

2 of 2 investments shown.

## Co-investors
- [Bridge Investment Fund](https://shizune.co/investors/profile/bridge-investment-fund) — VC Fund, 1 deal together
- [Noaber](https://shizune.co/investors/profile/noaber) — VC Fund, 1 deal together
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund, 1 deal together
- [ProSeed Venture Capital Fund](https://shizune.co/investors/profile/proseed-venture-capital-fund) — VC Fund, 1 deal together
- [The Challenge Fund](https://shizune.co/investors/profile/the-challenge-funds) — VC Fund, 1 deal together

## About Docor International Management

VC Fund · Tel Aviv, Israel

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

5 contacts available at Docor International Management.

| Name | Title | Profile |
| --- | --- | --- |
| Adi Goldin | Director of business development | https://shizune.co/investors/profile/adi-goldin |
| Anat Klein | Member | https://shizune.co/investors/profile/anat-klein |
| Andre Betting | Foundation Executive Director | https://shizune.co/investors/profile/andre-betting |
| Gideon Frank | Member | https://shizune.co/investors/profile/gideon-frank |
| Rien Van Gendt | Member | https://shizune.co/investors/profile/rien-van-gendt |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Adi Goldin invest in?

Adi Goldin invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series C and Series E stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Adi Goldin last invest?

The most recent investment recorded for Adi Goldin closed in Nov 2012. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co